Original filing text · Part II

Item 1 — Legal Proceedings

Kiniksa Pharmaceuticals International, Plc · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

We are not party to any material legal proceedings.